Search

everythinglearnresearchcommunity

for

Search:↓

Hirsutism is excessive male-pattern hair growth in women, often caused by hormonal imbalances, and requires ongoing treatment to manage.

New sulfur-containing steroid analogs show promise for more targeted medical treatments.

The review found no clear link between vitamin D receptor gene variations and polycystic ovary syndrome.

CD98hc's role in skin health decreases with age.

Autoimmune diseases can cause hair loss, and early treatment is important to prevent permanent damage.

Androgens may influence T cells, contributing to higher autoimmune liver disease risk in women.

Hormone treatments can help with women's skin and hair disorders, but they need careful monitoring and more research.

People with pemphigus are more likely to have conditions like hypothyroidism, inflammatory bowel disease, and diabetes.

Epilepsy and certain epilepsy drugs can lead to reproductive problems in women, but changing medication might improve these issues.

Certain 4-azasteroids are effective at blocking the enzyme that processes testosterone in human skin and could help treat acne, excessive hair growth, and male pattern baldness.

Finasteride treatment changes brain steroid levels and receptors, affecting brain function even after stopping treatment.

Finasteride and flutamide both reduce hair growth, but finasteride has fewer side effects.

APS-1 in Italy shows diverse AIRE mutations and various autoimmune issues.

MicroRNAs are important for skin health and could be targets for new skin disorder treatments.

Lower CD200R1 on certain immune cells is linked to more severe rheumatoid arthritis and immune imbalance.

New treatments for PCOS focus on insulin resistance and reducing testosterone levels, along with traditional hormone therapies.

Steroidogenic isoenzymes may help improve treatments for common hair loss.

Certain HSD3B1 gene types are linked to worse prostate cancer outcomes and affect treatment response and other health conditions.

New treatments targeting immune pathways show promise for severe hair loss but need more research for safety and effectiveness.

Nonclassic congenital adrenal hyperplasia is a genetic disorder causing hormone imbalances, affecting fertility and requiring personalized treatment.

Amenorrhea is when a woman doesn't have periods, with primary amenorrhea starting by age 15 or within five years of breast development, and secondary amenorrhea when periods stop for three months. It affects 3-4% of women not pregnant, breastfeeding, or in menopause, mainly due to polycystic ovary syndrome, hypothalamic amenorrhea, hyperprolactinemia, and ovarian failure.

Birth control pills and cyproterone acetate can help treat acne in women, especially when linked to hormonal issues.

The document concludes that managing hirsutism involves identifying the cause, using a scoring system for severity, combining cosmetic and medical treatments, encouraging weight loss, and providing psychological support, while noting the need for more research on drug treatments.

Recent genetic insights show that low-renin hypertension includes a range from essential hypertension to secondary or familial forms, affecting diagnosis and treatment.

With careful management, people with congenital adrenal hyperplasia can have successful pregnancies and become parents.

New compounds may soon be tested to treat excessive hair growth in women.

Researchers found new potential but less potent rat enzyme inhibitors using a 3D model.

Antiandrogens have important biological effects, but more research is needed to understand them fully and compare their effectiveness and side effects to other treatments.

The antiandrogen 11α-hydroxyprogesterone effectively reduces skin oil and cholesterol when applied to the skin.

Tannic acid helps wounds heal faster in rats by activating certain cell signals and reducing inflammation.